Microbix Biosystems Inc. (TSE:MBX – Get Free Report) shares traded down 4.8% on Friday . The company traded as low as C$0.30 and last traded at C$0.30. 187,287 shares traded hands during mid-day trading, an increase of 179% from the average session volume of 67,151 shares. The stock had previously closed at C$0.32.
Microbix Biosystems Stock Down 4.8 %
The company has a quick ratio of 5.57, a current ratio of 8.53 and a debt-to-equity ratio of 24.53. The firm has a market capitalization of C$41.23 million, a PE ratio of 10.50 and a beta of 0.25. The business’s 50-day moving average price is C$0.33 and its 200-day moving average price is C$0.37.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
See Also
- Five stocks we like better than Microbix Biosystems
- Consumer Discretionary Stocks Explained
- Qualcomm Stock: AI-Powered Growth Despite Volatility
- EV Stocks and How to Profit from Them
- Salesforce Stock: Meeting Recap, AI Focus, and Forecast
- Insider Trading – What You Need to Know
- Is CAVA Overextended? A Closer Look at This High-Flying Stock
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
